Cash flow Abbott Laboratories Swiss Exchange

Stocks

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange Other stock markets 01:35:33 04/08/26 am AEST			5-day change	1st Jan Change
86.50 ^CHF	+1.76%		+2.37%	-12.63%

10:34pm	Is everything under control?
01/08	Amgen discloses data breach involving patient health information	RE

e4c7ad8504cc3d81d0150.tAIfpLgKm7v1FDzlVEFJActRmi8-cBINEg9n2tPN05A.x1ZW1dZuytPDVkqsHSo7Vo4eql1YPEh_dlcTieWu5-TbZHjJ2mvV9ZlBbQ

Published financial data: ABBOTT LABORATORIES

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	43.08B	43.65B	40.11B	41.95B	44.33B
Total Revenues	43.08B	43.65B	40.11B	41.95B	44.33B
Cost of Goods Sold, Total	18.07B	19.08B	17.92B	18.64B	19.21B
Gross Profit	25.01B	24.57B	22.19B	23.31B	25.12B
Selling General & Admin Expenses, Total	11.01B	10.7B	10.38B	11.11B	11.63B
R&D Expenses	2.74B	2.74B	2.62B	2.82B	2.89B
Amortization of Goodwill and Intangible Assets - (IS)	2.05B	2.01B	1.97B	1.88B	1.68B
Other Operating Expenses, Total	15.79B	15.46B	14.97B	15.81B	16.2B
Operating Income	9.22B	9.11B	7.22B	7.5B	8.92B
Interest Expense, Total	-533M	-558M	-637M	-559M	-493M
Interest And Investment Income	43M	183M	385M	344M	308M
Net Interest Expenses	-490M	-375M	-252M	-215M	-185M
Currency Exchange Gains (Loss)	-1M	-2M	-41M	27M	50M
Other Non Operating Income (Expenses)	7M	-40M	-22M	-166M	-42M
EBT, Excl. Unusual Items	8.73B	8.7B	6.9B	7.14B	8.74B
Restructuring Charges	-509M	-234M	-144M	-129M	-274M
Merger & Related Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-45M	-39M	-	-
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-14M	-111M	-100M	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	42M	-	-
EBT, Incl. Unusual Items	8.21B	8.31B	6.66B	7.01B	8.47B
Income Tax Expense	1.14B	1.37B	941M	-6.39B	1.94B
Earnings From Continuing Operations	7.07B	6.93B	5.72B	13.4B	6.52B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	7.07B	6.93B	5.72B	13.4B	6.52B
Net Income - (IS)	7.07B	6.93B	5.72B	13.4B	6.52B
Preferred Dividend and Other Adjustments	29M	28M	22M	51M	24M
Net Income to Common Incl Extra Items	7.04B	6.9B	5.7B	13.35B	6.5B
Net Income to Common Excl. Extra Items	7.04B	6.9B	5.7B	13.35B	6.5B
Per Share Items
Net EPS - Basic	3.97	3.94	3.28	7.67	3.73
Basic EPS - Continuing Operations	3.97	3.94	3.28	7.67	3.73
Basic Weighted Average Shares Outstanding	1.78B	1.75B	1.74B	1.74B	1.74B
Net EPS - Diluted	3.94	3.91	3.26	7.64	3.72
Diluted EPS - Continuing Operations	3.94	3.91	3.26	7.64	3.72
Diluted Weighted Average Shares Outstanding	1.79B	1.76B	1.75B	1.75B	1.75B
Normalized Basic EPS	3.08	3.1	2.48	2.57	3.14
Normalized Diluted EPS	3.05	3.08	2.47	2.55	3.12
Dividend Per Share	1.82	1.92	2.08	2.24	2.4
Payout Ratio	45.28	47.73	62.14	28.62	63.09
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	12.76B	12.38B	10.46B	10.71B	12.03B
EBITA	11.26B	11.13B	9.19B	9.37B	10.6B
EBIT	9.22B	9.11B	7.22B	7.5B	8.92B
EBITDAR	13.12B	12.74B	10.82B	11.08B	12.42B
Effective Tax Rate - (Ratio)	13.88	16.53	14.12	-91.1	22.94
Current Domestic Taxes	859M	1.31B	528M	497M	387M
Current Foreign Taxes	790M	723M	874M	1.08B	1.11B
Total Current Taxes	1.65B	2.03B	1.4B	1.57B	1.5B
Deferred Domestic Taxes	-355M	-610M	-382M	-459M	-257M
Deferred Foreign Taxes	-154M	-49M	-79M	-7.5B	698M
Total Deferred Taxes	-509M	-659M	-461M	-7.96B	441M
Normalized Net Income	5.46B	5.44B	4.32B	4.46B	5.46B
Interest Capitalized	-	-	-	-	-
Non-Cash Pension Expense	-277M	-399M	-504M	-556M	-622M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	2.74B	2.89B	2.74B	2.84B	2.94B
Net Rental Expense, Total	359M	355M	356M	366M	391M
Imputed Operating Lease Interest Expense	78.22M	85.21M	107M	105M	105M
Imputed Operating Lease Depreciation	281M	270M	249M	261M	286M
Stock-Based Comp., Other (Total)	640M	685M	644M	673M	664M
Total Stock-Based Compensation	640M	685M	644M	673M	664M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	9.8B	9.88B	6.9B	7.62B	8.52B
Short Term Investments	450M	288M	383M	351M	417M
Trading Asset Securities, Total	-	-	-	1M	-
Total Cash And Short Term Investments	10.25B	10.17B	7.28B	7.97B	8.94B
Accounts Receivable, Total	6.49B	6.22B	6.56B	6.92B	7.93B
Total Receivables	6.49B	6.22B	6.56B	6.92B	7.93B
Inventory	5.16B	6.17B	6.57B	6.19B	6.49B
Prepaid Expenses	2.05B	2.25B	2.09B	2.18B	2.53B
Other Current Assets, Total	292M	412M	169M	390M	108M
Total Current Assets	24.24B	25.22B	22.67B	23.66B	26B
Gross Property Plant And Equipment	20.52B	21.33B	23.06B	23.82B	26.35B
Accumulated Depreciation	-10.4B	-11.05B	-11.78B	-12.08B	-13.41B
Net Property Plant And Equipment	10.11B	10.28B	11.28B	11.73B	12.94B
Long-term Investments	512M	468M	485M	573M	595M
Goodwill	23.23B	22.8B	23.68B	23.11B	24.04B
Other Intangibles, Total	12.74B	10.45B	8.82B	6.65B	5.53B
Deferred Tax Assets Long-Term	3.97B	-	-	15.38B	-
Other Long-Term Assets, Total	391M	5.22B	6.29B	313M	17.62B
Total Assets	75.2B	74.44B	73.21B	81.41B	86.71B
Liabilities
Accounts Payable, Total	4.41B	4.61B	4.3B	4.2B	4.24B
Accrued Expenses, Total	6.46B	7.04B	6.54B	6.46B	7.17B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	754M	2.25B	1.08B	1.5B	3.03B
Current Portion of Leases	245M	230M	245M	254M	276M
Current Income Taxes Payable	306M	343M	492M	594M	569M
Other Current Liabilities	928M	1.02B	1.19B	1.16B	1.2B
Total Current Liabilities	13.1B	15.49B	13.84B	14.16B	16.5B
Long-Term Debt	17.3B	14.52B	13.6B	12.68B	9.9B
Long-Term Leases	956M	943M	949M	896M	931M
Pension & Other Post Retirement Benefits	2.74B	1.78B	1.96B	1.88B	2.12B
Deferred Tax Liability Non Current	1.39B	991M	568M	512M	559M
Other Non Current Liabilities	3.68B	3.8B	3.47B	3.39B	3.94B
Total Liabilities	39.17B	37.53B	34.39B	33.51B	33.94B
Common Stock, Total	24.47B	24.71B	24.87B	25.15B	25.53B
Retained Earnings	31.53B	35.26B	37.55B	47.26B	49.78B
Treasury Stock	-11.82B	-15.23B	-15.98B	-16.84B	-17.18B
Comprehensive Income and Other	-8.37B	-8.05B	-7.84B	-7.91B	-6B
Total Common Equity	35.8B	36.69B	38.6B	47.66B	52.13B
Minority Interest	222M	219M	224M	237M	641M
Total Equity	36.02B	36.9B	38.83B	47.9B	52.77B
Total Liabilities And Equity	75.2B	74.44B	73.21B	81.41B	86.71B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.76B	1.74B	1.74B	1.73B	1.74B
ECS Total Common Shares Outstanding	1.76B	1.74B	1.73B	1.73B	1.74B
Book Value / Share	20.29	21.11	22.26	27.52	30.02
Tangible Book Value	-168M	3.43B	6.11B	17.91B	22.57B
Tangible Book Value Per Share	-0.1	1.98	3.52	10.34	13
Total Debt	19.25B	17.95B	15.87B	15.33B	14.14B
Net Debt	9B	7.78B	8.59B	7.36B	5.2B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-695M	-2.21B	-3.06B	-4.69B	-6.37B
Debt Equivalent Oper. Leases	2.87B	2.84B	2.85B	2.93B	3.13B
Minority Interest, Total (Incl. Fin. Div)	222M	219M	224M	237M	641M
Equity Method Investments, Total	256M	169M	141M	139M	131M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.38B	1.69B	1.82B	1.65B	1.61B
Inventories - Work In Process, Total	694M	680M	807M	840M	904M
Inventories - Finished Goods, Total	3.08B	3.8B	3.95B	3.7B	3.98B
Land - (BS)	525M	511M	529M	528M	541M
Buildings, Total	4.01B	4.05B	4.16B	4.21B	4.54B
Machinery, Total	13.53B	14.16B	15.18B	15.52B	17.57B
Full Time Employees	113K	115K	114K	114K	115K
Accumulated Allowance for Doubtful Accounts (Supple)	313M	262M	241M	247M	290M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	7.07B	6.93B	5.72B	13.4B	6.52B
Depreciation & Amortization - CF	1.49B	1.25B	1.28B	1.34B	1.43B
Amortization of Goodwill and Intangible Assets - (CF)	2.05B	2.01B	1.97B	1.88B	1.68B
Depreciation & Amortization, Total	3.54B	3.27B	3.24B	3.22B	3.12B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	55M	215M	126M	482M	65M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	640M	685M	644M	673M	664M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	-	-	-	-	-
Change In Accounts Receivable	-383M	-68M	-356M	-691M	-652M
Change In Inventories	-456M	-1.41B	-232M	-58M	195M
Change In Accounts Payable	1.29B	420M	-760M	356M	954M
Change In Income Taxes	-908M	-383M	-585M	-8.03B	-5M
Change in Other Net Operating Assets	-312M	-75M	-542M	-796M	-1.3B
Cash from Operations	10.53B	9.58B	7.26B	8.56B	9.57B
Capital Expenditure	-1.88B	-1.78B	-2.2B	-2.21B	-2.17B
Cash Acquisitions	-187M	-	-877M	-	-105M
Divestitures	134M	48M	40M	1M	-
Investment in Marketable and Equity Securities, Total	-96M	-33M	-116M	-141M	-164M
Other Investing Activities, Total	26M	22M	22M	9M	18M
Cash from Investing	-2.01B	-1.74B	-3.13B	-2.34B	-2.42B
Short Term Debt Issued, Total	-	47M	21M	-	-
Long-Term Debt Issued, Total	4M	7M	2M	223M	5M
Total Debt Issued	4M	54M	23M	223M	5M
Short Term Debt Repaid, Total	-204M	-	-	-100M	-115M
Long-Term Debt Repaid, Total	-48M	-753M	-2.5B	-660M	-1.5B
Total Debt Repaid	-252M	-753M	-2.5B	-760M	-1.62B
Issuance of Common Stock	255M	167M	167M	264M	396M
Repurchase of Common Stock	-2.3B	-3.8B	-1.23B	-1.3B	-893M
Repurchase of Preferred Stock	-	-	-	-	-
Common Dividends Paid	-3.2B	-3.31B	-3.56B	-3.84B	-4.12B
Common & Preferred Stock Dividends Paid	-3.2B	-3.31B	-3.56B	-3.84B	-4.12B
Other Financing Activities, Total	-	-	-	-	-82M
Cash from Financing	-5.49B	-7.64B	-7.09B	-5.4B	-6.31B
Foreign Exchange Rate Adjustments	-70M	-122M	-23M	-96M	71M
Net Change in Cash	2.96B	83M	-2.99B	720M	906M
Supplemental Items
Cash Interest Paid	544M	563M	662M	604M	545M
Cash Income Tax Paid (Refund)	1.94B	1.86B	1.48B	1.72B	1.93B
Levered Free Cash Flow	7.68B	7.36B	4.99B	5.61B	6.29B
Unlevered Free Cash Flow	8.02B	7.71B	5.39B	5.96B	6.6B
Change In Net Working Capital	37M	162M	809M	410M	585M
Net Debt Issued / Repaid	-248M	-699M	-2.48B	-537M	-1.61B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.8	7.61	6.11	6.06	6.63
Return on Total Capital	10.65	10.34	8.24	7.94	8.57
Return On Equity %	20.49	19.01	15.11	30.91	12.96
Return on Common Equity	20.53	19.05	15.14	30.95	13.03
Margin Analysis
Gross Profit Margin %	58.06	56.28	55.32	55.56	56.66
SG&A Margin	25.55	24.52	25.89	26.48	26.24
EBITDA Margin %	29.61	28.36	26.09	25.54	27.15
EBITA Margin %	26.15	25.49	22.9	22.35	23.91
EBIT Margin %	21.4	20.88	18	17.87	20.12
Income From Continuing Operations Margin %	16.42	15.88	14.27	31.95	14.72
Net Income Margin %	16.42	15.88	14.27	31.95	14.72
Net Avail. For Common Margin %	16.35	15.82	14.21	31.83	14.66
Normalized Net Income Margin	12.67	12.45	10.76	10.64	12.32
Levered Free Cash Flow Margin	17.84	16.86	12.44	13.37	14.19
Unlevered Free Cash Flow Margin	18.61	17.66	13.43	14.2	14.88
Asset Turnover
Asset Turnover	0.58	0.58	0.54	0.54	0.53
Fixed Assets Turnover	4.26	4.28	3.72	3.65	3.59
Receivables Turnover (Average Receivables)	6.68	6.87	6.28	6.22	5.97
Inventory Turnover (Average Inventory)	3.55	3.37	2.81	2.92	3.03
Short Term Liquidity
Current Ratio	1.85	1.63	1.64	1.67	1.58
Quick Ratio	1.28	1.06	1	1.05	1.02
Operating Cash Flow to Current Liabilities	0.8	0.62	0.52	0.6	0.58
Days Sales Outstanding (Average Receivables)	54.66	53.12	58.16	58.85	61.15
Days Outstanding Inventory (Average Inventory)	102.73	108.35	129.78	125.28	120.48
Average Days Payable Outstanding	83.72	81.86	88.7	85.05	78.93
Cash Conversion Cycle (Average Days)	73.67	79.61	99.25	99.08	102.71
Long Term Solvency
Total Debt/Equity	53.44	48.63	40.88	32	26.79
Total Debt / Total Capital	34.83	32.72	29.02	24.24	21.13
LT Debt/Equity	50.67	41.9	37.47	28.33	20.52
Long-Term Debt / Total Capital	33.02	28.19	26.6	21.47	16.18
Total Liabilities / Total Assets	52.09	50.42	46.97	41.16	39.14
EBIT / Interest Expense	17.29	16.33	11.33	13.41	18.09
EBITDA / Interest Expense	24.61	22.82	16.98	19.82	25.2
(EBITDA - Capex) / Interest Expense	21.07	19.64	13.53	15.87	20.8
Total Debt / EBITDA	1.47	1.41	1.47	1.38	1.14
Net Debt / EBITDA	0.69	0.61	0.79	0.66	0.42
Total Debt / (EBITDA - Capex)	1.71	1.64	1.84	1.73	1.38
Net Debt / (EBITDA - Capex)	0.8	0.71	1	0.83	0.51
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	24.47	1.34	-8.12	4.59	5.67
Gross Profit, 1 Yr. Growth %	26.61	-1.7	-9.69	5.03	7.77
EBITDA, 1 Yr. Growth %	41.86	-2.84	-15.48	2.4	12.31
EBITA, 1 Yr. Growth %	44.48	-1.11	-17.44	2.05	13.07
EBIT, 1 Yr. Growth %	62.72	-0.99	-20.77	3.82	18.96
Earnings From Cont. Operations, 1 Yr. Growth %	58.15	-1.95	-17.45	134.18	-51.32
Net Income, 1 Yr. Growth %	57.31	-1.95	-17.45	134.18	-51.32
Normalized Net Income, 1 Yr. Growth %	68.41	-0.28	-20.6	3.43	19.97
Diluted EPS Before Extra, 1 Yr. Growth %	58.23	-0.76	-16.62	134.36	-51.31
Accounts Receivable, 1 Yr. Growth %	1.14	-4.15	5.58	5.48	14.5
Inventory, 1 Yr. Growth %	2.89	19.7	6.43	-5.72	4.75
Net Property, Plant and Equip., 1 Yr. Growth %	-0.18	1.64	9.71	4.05	10.3
Total Assets, 1 Yr. Growth %	3.65	-1.01	-1.64	11.2	6.51
Tangible Book Value, 1 Yr. Growth %	-97.08	-2.14K	77.95	193.16	26.02
Common Equity, 1 Yr. Growth %	9.21	2.47	5.23	23.47	9.37
Cash From Operations, 1 Yr. Growth %	33.31	-9.04	-24.21	17.86	11.78
Capital Expenditures, 1 Yr. Growth %	-13.41	-5.73	23.92	0.23	-1.63
Levered Free Cash Flow, 1 Yr. Growth %	42.42	-4.11	-32.01	12.41	12.11
Unlevered Free Cash Flow, 1 Yr. Growth %	39.76	-3.74	-29.92	10.59	10.71
Dividend Per Share, 1 Yr. Growth %	18.95	5.49	8.33	7.69	7.14
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	16.2	12.31	-3.5	-1.97	5.13
Gross Profit, 2 Yr. CAGR %	15.73	11.95	-5.78	-2.61	6.39
EBITDA, 2 Yr. CAGR %	28.12	18.68	-9.38	-6.97	7.24
EBITA, 2 Yr. CAGR %	29.73	21.04	-9.64	-8.21	7.42
EBIT, 2 Yr. CAGR %	39.2	29.17	-11.43	-9.3	11.13
Earnings From Cont. Operations, 2 Yr. CAGR %	38.49	24.53	-10.04	39.04	6.77
Net Income, 2 Yr. CAGR %	38.49	24.19	-10.04	39.04	6.77
Normalized Net Income, 2 Yr. CAGR %	45.25	32.1	-11.01	-9.14	12.48
Diluted EPS Before Extra, 2 Yr. CAGR %	38.3	25.31	-9.04	39.78	6.82
Accounts Receivable, 2 Yr. CAGR %	9.35	-1.54	0.6	5.53	9.9
Inventory, 2 Yr. CAGR %	9.31	10.98	12.87	0.17	-0.63
Net Property, Plant and Equip., 2 Yr. CAGR %	6.16	0.73	5.6	6.84	7.13
Total Assets, 2 Yr. CAGR %	5.25	1.29	-1.33	4.58	8.83
Tangible Book Value, 2 Yr. CAGR %	-86.44	-22.69	503.02	128.4	92.21
Common Equity, 2 Yr. CAGR %	7.31	5.78	3.84	13.98	16.21
Cash From Operations, 2 Yr. CAGR %	31.02	10.12	-16.97	-5.49	14.78
Capital Expenditures, 2 Yr. CAGR %	7.28	-9.65	8.08	11.44	-0.71
Levered Free Cash Flow, 2 Yr. CAGR %	41.4	18.19	-19.37	-12.58	12.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	37.15	17.22	-17.97	-11.96	10.65
Dividend Per Share, 2 Yr. CAGR %	17.42	12.02	6.9	8.01	7.42
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	12.1	11.02	5.04	-0.88	0.51
Gross Profit, 3 Yr. CAGR %	11.83	9.58	4.22	-2.31	0.74
EBITDA, 3 Yr. CAGR %	21.48	16.79	5.98	-5.61	-0.94
EBITA, 3 Yr. CAGR %	23.26	18.46	6.55	-5.9	-1.6
EBIT, 3 Yr. CAGR %	33.92	24.2	9.75	-6.61	-0.72
Earnings From Cont. Operations, 3 Yr. CAGR %	44.7	23.43	8.58	23.76	-2.01
Net Income, 3 Yr. CAGR %	44	23.43	8.38	23.76	-2.01
Normalized Net Income, 3 Yr. CAGR %	41.73	28.07	11.49	-6.44	0.34
Diluted EPS Before Extra, 3 Yr. CAGR %	44.35	23.81	9.4	24.7	-1.65
Accounts Receivable, 3 Yr. CAGR %	7.77	4.65	0.78	2.2	8.44
Inventory, 3 Yr. CAGR %	10.75	12.67	9.44	6.3	1.67
Net Property, Plant and Equip., 3 Yr. CAGR %	10.17	4.63	3.64	5.08	7.99
Total Assets, 3 Yr. CAGR %	3.83	3.12	0.31	2.68	5.22
Tangible Book Value, 3 Yr. CAGR %	-75.68	-27.83	2.07	374.16	87.33
Common Equity, 3 Yr. CAGR %	5.46	5.67	5.6	10.01	12.42
Cash From Operations, 3 Yr. CAGR %	18.69	16.01	-2.78	-6.69	-0.05
Capital Expenditures, 3 Yr. CAGR %	10.58	2.75	0.38	5.4	6.9
Levered Free Cash Flow, 3 Yr. CAGR %	16.65	24.18	-1.79	-9.92	-5.02
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.38	21.84	-1.33	-9.38	-4.98
Dividend Per Share, 3 Yr. CAGR %	16.2	13.3	10.78	7.17	7.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.61	9.77	5.58	5.63	5.08
Gross Profit, 5 Yr. CAGR %	16.27	9.09	4.41	4.53	5.08
EBITDA, 5 Yr. CAGR %	22.79	15.75	8.02	6.63	6.48
EBITA, 5 Yr. CAGR %	24.49	17.76	8.83	6.97	6.9
EBIT, 5 Yr. CAGR %	23.43	25.41	13.47	9.52	10.3
Earnings From Cont. Operations, 5 Yr. CAGR %	46.08	81.4	19.65	29.45	7.85
Net Income, 5 Yr. CAGR %	38.25	70.8	19.3	29.45	7.74
Normalized Net Income, 5 Yr. CAGR %	29.57	31.2	17.61	11.52	11.89
Diluted EPS Before Extra, 5 Yr. CAGR %	40.88	81.65	20	29.97	8.36
Accounts Receivable, 5 Yr. CAGR %	14.84	3.45	4.84	5	4.33
Inventory, 5 Yr. CAGR %	16.2	11.38	11.6	7.49	5.3
Net Property, Plant and Equip., 5 Yr. CAGR %	12.13	6.2	8.32	5.51	5.02
Total Assets, 5 Yr. CAGR %	7.38	-0.48	1.74	3.7	3.63
Tangible Book Value, 5 Yr. CAGR %	-54.18	-25.13	-12.15	14.42	31.48
Common Equity, 5 Yr. CAGR %	11.76	3.49	4.81	8.92	9.72
Cash From Operations, 5 Yr. CAGR %	26.88	11.46	2.88	6.88	3.9
Capital Expenditures, 5 Yr. CAGR %	10.95	9.38	9.57	6.14	-0.06
Levered Free Cash Flow, 5 Yr. CAGR %	34.36	13.58	0.61	7.86	3.6
Unlevered Free Cash Flow, 5 Yr. CAGR %	33.95	11.6	0.11	6.93	3.3
Dividend Per Share, 5 Yr. CAGR %	11.74	12.3	12.39	11.16	9.42